Cyclosporin pp 303-323 | Cite as

Pathological effects of cyclosporin A in experimental models

  • Paul H. Whiting
  • Angus W. Thompson

Abstract

Cyclosporin A (CsA) administered either alone or in combination with steroids or azathioprine, is now the immunotherapeutic agent of choice in the management of organ allograft rejection. The prospective value of CsA in the treatment of certain autoimmune diseases is presently being evaluated in numerous clinical trials. However, it has been demonstrated both in animals and man that CsA possesses many adverse side-effects, which include renal and hepatic dysfunction, hypertension, mild tremors, hirsutism, abnormal glucose homeostasis and gingival hypertrophy. Some degree of renal impairment is observed in virtually all patients receiving CsA, and it is this attendant nephrotoxicity which limits its clinical use.

Keywords

Glomerular Filtration Rate Renal Transplant Recipient Pathological Effect Hepatic Drug Metabolism Lithium Clearance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mihatsch, M. J., Thiel, G. and Ryffel, B. (1986) Morphology of ciclosporin nephropathy. Prog. Allergy, 38, 447–457.PubMedGoogle Scholar
  2. 2.
    Mihatsch, M. J., Ryffel, B., Hermle, M, Brunner, F. P. and Thiel G. (1986) Morphology of cyclosporine nephrotoxicity in the rat. Clin. Nephrol., 25 (Suppl. 1), S2–S8.PubMedGoogle Scholar
  3. 3.
    Myers, B. D., Ross, J., Newton, L., leutscher, J. and Perlroth, M. (1984) Cyclosporine-associated chronic nephropathy. N. Engl. J. Med., 311, 699–705PubMedGoogle Scholar
  4. 4.
    Kahan, B. D. (1985) Clinical summation: an algorithm for the management of patients with cyciosporine-induced renal dysfunction. Transplant. Proc., 17 (Suppl. 4), 303–308.PubMedGoogle Scholar
  5. 5.
    Klintmalm, G. B. G., Iwatsuki, I. and Starzl, T. (1981) Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet, 1, 470–471.PubMedGoogle Scholar
  6. 6.
    Calne, R. Y., White, D. J. G., Evans, D. B., Thiru, S., Henderson, R. G., Hamilton, D. V., Rolles, K., McMaster, P., Duffy, T. J., MacDougall, B. R. D. and Williams, R. (1981) Cyclosporin A in cadaveric organ Transplantation. Br. Med. J., 282, 934–936.Google Scholar
  7. 7.
    Hows, J. M., Palmer, S., Want, S., Dearden, C. and Gordon-Smith, E. C. (1981) Serum levels of cyclosporin A and nephrotoxicity in bone marrow transplant patients. Lancet, 2, 145–146.PubMedGoogle Scholar
  8. 8.
    Thomson, A. W., Whiting, P. H. and Simpson, J. G. (1984) Cyclosporine: Immunology, toxicity and pharmacology in experimental animals. Agents Actions, 15, 306–327.PubMedGoogle Scholar
  9. 9.
    McAuley, F. T., Simpson, J. G., Thomson, A. W. and Whiting, P. H. (1986) The predictive value of enzymuria in cyclosporin A-induced renal toxicity in the rat. Toxicol. Lett. 32, 163–169.PubMedGoogle Scholar
  10. 10.
    Whiting, P. H., Thomson, A. W. and Simpson, J. G. (1986) Cyclosporine and renal enzyme excretion. Clin. Nephrol., 25 (Suppl. 1), S100–S104.PubMedGoogle Scholar
  11. 11.
    Pfaller, W., Kotanko, P. and Bazzanella, A. (1986) Morphological and biochemical observations in rat nephron epithelia following cyclosporine A (CsA) treatment. Clin. Nephrol., 25 (Suppl. 1), S105–S110.PubMedGoogle Scholar
  12. 12.
    Bertani, T., Perico, R, Abbate, M., Battaglia, C. and Remuzzi, G. (1987) Renal injury induced by long-term administration of cyclosporin A to rats. Am. J. Pathol., 127, 569–579.PubMedGoogle Scholar
  13. 13.
    Simpson, J. G., Saunders, N. J., Thomson, K. J. and Whiting, P. H. (1988) Chronic renal damage caused by cyclosporine. Transplant. Proc., 20, (Suppl. 3), 792–799.PubMedGoogle Scholar
  14. 14.
    Battle, D. C., Gutterman, C., Tarka, J. and Prassad, R. (1986) Effect of short-term cyclosporine A administration on urinary acidification. Clin. Nephrol., 25 (Suppl. 1), S62–S69.Google Scholar
  15. 15.
    Gnutzmann, K. R, Hering, K. and Gutsche, H-U. (1986) Effect of cyclosporine on the diluting capacity of the kidney. Clin. Nephrol., 25 (Suppl. 1), S51–S56.PubMedGoogle Scholar
  16. 16.
    Whiting, P. H. and Simpson, J. G. (1988) Lithium clearance measurements as an indicator of cyclosporin A nephrotoxicity in the rat. Clin. Sci., 74, 173–178.PubMedGoogle Scholar
  17. 17.
    Dieperink, R, Leyssac, P. P., Kemp, E., Steinbruckl, D. and Starklint, H.,(1986). Glomerulotubular function in cyclosporin A treated rats. Clin. Nephrol., 25 (Suppl. 1), S70–S74.PubMedGoogle Scholar
  18. 18.
    Dieperink, H., Kemp, E., Leyssac, P. P. and Starklint, H. (1986) Cyclosporine A: effectiveness and toxicity in a rat model. Clin. Nephrol., 25 (Suppl. 1), S46–S50.PubMedGoogle Scholar
  19. 19.
    Dieperink, R, Starklint, H. and Leyssac, P. P. (1983) Nephrotoxicity of cyclosporin — an animal model: study of the nephrotoxic effect of cyclosporine on overall renal and tubular function in conscious rats. Transplant. Proc., 15, (Suppl. 15), 2736–2741.Google Scholar
  20. 20.
    English, J., Evan, A., Houghton, D. G and Bennett, W. M. (1987) Cyclosporine-induced acute renal dysfunction in the rat. Transplantation, 44, 135–141.PubMedGoogle Scholar
  21. 21.
    Nitta, K., Friedman, A. L., Nicastri, D., Soonmyoung Paik and Friedman, E. A. (1987) Granular juxtaglomerular cell hyperplasia caused by cyclosporine. Transplantation, 44, 417–421.PubMedGoogle Scholar
  22. 22.
    Gerkens, J. F., Bhagwandeen, S. B., Dosen, P. J. and Smith, A. J. (1984) The effect of salt intake on cyclosporine-induced impairment of renal function in rats. Transplantation, 38, 412–417.PubMedGoogle Scholar
  23. 23.
    McAuley, F. T., Simpson, J. G., Thomson, A. W. and Whiting, P. H. (1986) Cyclosporin A induced nephrotoxicity in the rat: relationship to increased plasma renin activity. Agents Actions, 23, 676–680.Google Scholar
  24. 24.
    McAuley, F. T., Whiting, P. H., Thomson, A. W. and Simpson, J. G. (1987) The influence of enalapril or spironolactone on experimental cyclosporin nephrotoxicity. Biochem. Pharmacol., 36, 699–703.PubMedGoogle Scholar
  25. 25.
    Nemlander, A., Soots, A., Von Willebrand, E., Tallqvist, G. and Häyry, P. (1982) Effect of cyclosporin A on the in situ inflammatory response of rat renal allograft rejection. Scand. J. Immunol., 16, 91–102.PubMedGoogle Scholar
  26. 26.
    Duncan, J. I., Whiting, P. R, Simpson, J. G., and Thomson, A. W. (1986) Alleviation of cyclosporine-mediated nephrotoxicity by phenobarbitone, during the suppression of Graft-Versus-Host reactivity. Transplant. Proc., 18, 645–649.Google Scholar
  27. 27.
    Duncan, J. I., Heys, S. D., Thomson, A. W., Simpson, J. G. and Whiting, P. H. (1988) Influence of the hepatic drug-metabolizing enzyme inducer phenobarbitone on cyclosporine nephrotoxicity and hepatotoxicity in renal-allografted rats. Transplantation, 45, 693–697.PubMedGoogle Scholar
  28. 28.
    Whiting, P. H. and Burke, M. D. (1986) The role of drug metabolism in cyclosporine A nephrotoxicity. Clin. Nephrol., 25 (Suppl. 1), S111–S115.PubMedGoogle Scholar
  29. 29.
    Gumbleton, M., Brown, J. E., Hawksworth, G. and Whiting, P. H. (1985) The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporin A nephrotoxicity. Transplantation, 46, 545–455.Google Scholar
  30. 30.
    Cunningham, C., Gavin, M. P., Whiting, P. H., Burke, M. D., Macintyre, F., Thomson, A. W. and Simpson, J. G. (1984) Serum cyclosporin levels, hepatic drug metabolism and renal tubulofcoxicity. Biochem. Pharmacol., 33, 2857–2861.PubMedGoogle Scholar
  31. 31.
    Cunningham, C., Burke, M. D., Wheatley, D. N., Thomson, A. W., Simpson, J. G. and Whiting, P. H. (1985) Amelioration of cyclosporin-induced nephrotoxicity in rats by induction of hepatic drug metabolism. Biochem. Pharmacol., 34, 573–578.PubMedGoogle Scholar
  32. 32.
    Schwass, D. E., Sasaki, A. W., Houghton, D. C., Benner, K. E. and Bennett, W. M. (1986) Effect of phenobarbital and Cimetidine on experimental cyclosporine nephrotoxicity: preliminary observations. Clin. Nephrol., 25 (Suppl. 1), S117–S120.PubMedGoogle Scholar
  33. 33.
    Yoshimura, R., Yoshimura, N., Kusunose, E., Kituta, T., Matsui, S., Hamashima, T., Kishimoto, T., Oka, T., Kusunose, M. and Maekawa, M. (1989) Role of kidney microsomal cytochrome P-450 in cyclosporine-induced nephropathy. Transplant Proc., 21, 934–936.PubMedGoogle Scholar
  34. 34.
    Whiting, P. H. and Simpson, J. G. (1983) The enhancement of cyclosporin A induced nephrotoxicity by gentamicin. Biochem. Pharmacol., 32, 2025–2028.PubMedGoogle Scholar
  35. 35.
    Whiting, P. H., Thomsoa A. W. and Simpson, J. G. (1983) Renal and hepatic function in rats treated with cyclosporin A in combination with gentamicin or cephalosporin antibiotics. Br. J. Exp. Pathol., 64, 693–701.PubMedGoogle Scholar
  36. 36.
    Ryffel, B., Müller, A. M. and Mihatsch, M. J. (1986) Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy. Clin. Nephrol, 25 (Suppl. 1), S121–S125.PubMedGoogle Scholar
  37. 37.
    Whiting, P. H., Cunningham, C., Thomson, A. W. and Simpson, A. W. (1984) Enhancement of high dose cyclosporin A toxicity by frusernide. Biochem. Pharmacol., 33, 1075–1079.PubMedGoogle Scholar
  38. 38.
    Racusen, L. C., McGraw, D. J. and Solez, K. (1985) Cyclosporine nephrotoxicity: effect of Clonidine and furosemide. Monogr. Appl Toxicol., 2, 419–428.Google Scholar
  39. 39.
    Brunner, F. P., Hermle, M., Mihatsch, M. J. and Thiel, G. (1986) Mannitol potentiates cyclosporine nephrotoxicity. Clin. Nephrol., 25 (Suppl. 1), S130–S136.PubMedGoogle Scholar
  40. 40.
    Mihatsch, M. J., Thiel, G., Spichtin, H. P., Oberholzer, M., Brunner, F. P., Harder, E., Olivieri, V., Bremer, R., Ryffel, B., Stöcklin, E., Torhorst, J., Gudat, F., Zollinger, H. U. and Loertscher, R. (1983) Morphological findings in kidney transplants after treatment with cyclosporine. Transplant Proc., 15 (Suppl. 1), 2821--2836.Google Scholar
  41. 41.
    Nield, G. H., Ivory, K. and Williams, D. G. (1984) Glomerular thrombosis and cortical infarction in cyclosporin-treated rabbits with acute serum sickness. Br. J. Exp. Pathol., 65, 133–144.Google Scholar
  42. 42.
    Neild, G. H., Ivory, K. and Williams, D. G. (1984) Severe systemic vascular necrosis in cyclosporin-treated rabbits with acute serum sickness. Br. J. Exp. Pathol, 65, 731–743.Google Scholar
  43. 43.
    Neild, G. H., Ivory, K. and Williams, D. G. (1986) Effects of cyclosporine on proteinuria in chronic serum sickness in rats. Clin. Nephrol., 25 (Suppl. 1), S186–S188.PubMedGoogle Scholar
  44. 44.
    Neild, G. H., Rocchi, G., Imberti, L., Fumagalli, F., Brown, Z., Remuzzi, G. and Williams, D. G. (1983) Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thrombosis Res., 32, 373–379.Google Scholar
  45. 45.
    Fairchilds, L., Cairns, H. S., Westwick, J. and Neild, G. H. (1989) Endothelium derived relaxant factor (EDRF) and cyclosporin (CS) nephrotoxicity. Transplant. Proc. (In press).Google Scholar
  46. 46.
    Ryffel, B., Donatsch, P., Hiestand, P. and Mihatsch, M. J. (1986) PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats. Clin. Nephrol., 25 (Suppl. 1), S95–S99.PubMedGoogle Scholar
  47. 47.
    Whiting, P. H., Thomson, K. J., Saunders, N. J. and Simpson, J. G. (1989) Cyclosporin A nephrotoxicity in streptozotocin-diabetic rats. Transplant. Proc., 21, 946–947.PubMedGoogle Scholar
  48. 48.
    Dieperink, H., Starklint, H., Kemp, E. and Leyssac, P. P. (1989) Mechanisms of cyclosporin A nephrotoxicity — rat to man. In: Bach, P. H. and Lock, E. A. (eds.) Nephrotoxicity: Extrapolation from in vitro to in vivo, and Animais to Man, pp. 277–284. (London: Plenum Press).Google Scholar
  49. 49.
    Critical issues in cyclosporine monitoring: report of the task force on cyclosporine monitoring. (1988) Clin. Chem., 33, 1269–1288.Google Scholar
  50. 50.
    Jones, M. C., Whiting, P. H., Innes, A., Propper, D. J., Edward, N. and Catto, G. R. D. (1989) Biochemical abnormalities in serum and urine from renal transplant recipients receiving cyclosporine. Transplant. Proc., 21, 1487–1489.PubMedGoogle Scholar
  51. 51.
    Blair, J. T., Thomson, A. W., Whiting, P. H, Davidson, R. J. L. and Simpson, J. G. (1982) Toxicity of the immunosuppressive agent cyclosporin A in the rat. J. Pathol., 138, 163–178.PubMedGoogle Scholar
  52. 52.
    Ryffel, B. (1982) Experimental toxicological studies with cyclosporin A. In: White, D. J. G. (ed.), Cyclosporin A, (Amsterdam: Elsevier), pp. 45–75.Google Scholar
  53. 53.
    Ryffel, B., Donatsch, P., Madörin, B. E., Matter, G., Rüttiman, G., Schön, H., Stoll, R. and Wilson, J. (1983) Toxicological evaluation of cyclosporin A. Arch. Toxicol., 53, 107–141.PubMedGoogle Scholar
  54. 54.
    Thomson, A. W., Whiting, P. H., Cameron, L D., Lessels, S. E. and Simpson, J. G. (1981) A toxicological study in rats receiving immunotherapeutic doses of cyclosporin A. Transplantation, 31, 121–124.PubMedGoogle Scholar
  55. 55.
    Heys, S. D., Duncan, J. I. and Whiting, P. H. (1988) Experimental cyclosporine nephrotoxicity in the rat: effect of biliary ligation and cannulation. Transplant. Proc., 20 (Suppl. 3), 845–849.PubMedGoogle Scholar
  56. 56.
    Whiting, P. H., Simpson, J. G., Davidson, R. J. L and Thomson, A. W. (1983). Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks. Br. J. Exp. Pathol., 64, 437–444.PubMedGoogle Scholar
  57. 57.
    Farthing, M. J. G., Clark, M. L., Pendry, A., Sloane, J. and Alexander, P. (1981). Nature of the toxicity of cyclosporin A in the rat. Biochem. Pharmacol., 30, 3311–3316.PubMedGoogle Scholar
  58. 58.
    Vine, W., Billiar, T., Simmons, R. and Bowers, L. (1988) Cyclosporine-induced hepatotoxicity: a microassay by hepatocytes in tissue culture. Transplant. Proc., 20 (Suppl. 3), 859–862.PubMedGoogle Scholar
  59. 59.
    Uemoto, S., Tanaka, K., Asonuma, K., Kitakado, Y., Katayama, T., Tanaka, M., Inomata, Y. and Ozawa, K. (1989) Effects of cyclosporine on oxidative phosphorylation and adenylate energy charge of regenerating rat liver. Transplant. Proc., 21, 924–925.PubMedGoogle Scholar
  60. 60.
    Grant, D., Black, R., Zhong, R., Watt, W. and Duff, C. (1988) The effect of cyclosporine on liver regeneration. Transplant. Proc., 20, 877–879.PubMedGoogle Scholar
  61. 61.
    Kahn, D., Lai, H. S., Romovacek, H., Makowka, L, Van Theil, D. and Starzl, T. (1988) Cyclosporine augments the regenerative response after partial hepatectomy in the rat. Transplant. Proc., 20, 850–852.PubMedGoogle Scholar
  62. 62.
    Leunissen, K., Teule, J., Degenaar, C. and van Hooff, J. (1988) The effect of cyclosporine on liver perfusion and liver synthetic function. Transplant. Proc., (In press).Google Scholar
  63. 63.
    Stone, B., Warty, V., Dindzans, V., and Van Thiel, D. (1988) The mechanism for cyclosporine-induced cholestasis in the rat. Transplant. Proc., 20, 841–844.PubMedGoogle Scholar
  64. 64.
    Siegl, H., Petric, R. and Ryffel, B. (1983) Effects of cyclosporine on the rennin-angiotensin-aldosterone system. Transplant. Proc., 15 (Suppl. 1), 2719–2725.Google Scholar
  65. 65.
    Baxter, C. R., Duggin, G. G., Hall, B. M., Horvath, J. S. and Tiller, D. J. (1984) Stimulation of renin release from rat renal cortical slices by cyclosporin A. Res. Commun. Chem. Pathol. Pharmacol., 43, 417–423.PubMedGoogle Scholar
  66. 66.
    Stahl, R. A. K. and Kudelka, S. (1986) Chronic cyclosporin A treatment reduces prostaglandin E2 formation in isolated glomeruli and papilla of rat kidneys. Clin. Nephrol., 25 (Suppl. 1), S78–S82.PubMedGoogle Scholar
  67. 67.
    Kawaguchi, A., Goldman, M. H., Shapiro, R., Foegh, M. L., Ramwell, P. W. and Lower, R. R. (1985) Increase in urinary thromboxane B2 in rats caused by cyclosporine. Transplantation, 40, 214–216.PubMedGoogle Scholar
  68. 68.
    Perico, N., Benigni, A., Zoja, C., Deiaini, F. and Remuzzi, G. (1986) Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A. Am. J. Physiol., 251, F581–F587.PubMedGoogle Scholar
  69. 69.
    Whiting, P. H., Barnard, N., Meilsch, A., Simpson, J. G. and Burke, M. D. (1988) Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat. Br. J. Exp. Pathol., 68, 777–786.Google Scholar
  70. 70.
    Murray, B. M. and Paller, M. S. (1986). Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats. Clin. Nephrol., 25 (Suppl 1), S37–S39.PubMedGoogle Scholar
  71. 71.
    Duggin, G. G., Baxter, C., Hall, B. M., Horvath, J. S. and Tiller, D. J. (1986) Influence of cyclosporine A (CSA) on intrarenal control of GFR. Clin. Nephrol., 25 (Suppl. 1), S43–S45.PubMedGoogle Scholar
  72. 72.
    Ryffel, B., Foxweli, B. M., Gee, A., Greiner, B., Woerly, G. and Mihatsch, M. J. (1988) Cyclosporine-relationship of side effects to mode of action. Transplantation, 46, 90S–96S.Google Scholar
  73. 73.
    Bantle, J. P., Nath, K. A., Sutherland, D. E. R., Najarian, J. S. and Ferris, T. F. (1985) Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch. Intern. Med., 145, 505–508.PubMedGoogle Scholar
  74. 74.
    Dieperink, H., Leyssac, P. P., Starklint, H. and Kemp, E. (1986) Nephrotoxicity of cyclosporin A. A lithium clearance and micropuncture study in rats. Eur. J. Clin. Invest., 16, 69–77.PubMedGoogle Scholar
  75. 75.
    Vincent, H., Wenting, G. J., Schalenkamp, M A., Jeekel, J. and Weimar, W. (1988) Impaired fractional excretion of lithium: a very early marker of cyclosporine nephrotoxicity. Transplant. Proc., 19, 4147–4148.Google Scholar
  76. 76.
    Whiting, P. H., Burke, M. D. and Thomson, A. W. (1986) Drug interactions with cyclosporine: implications from animal studies. Transplant. Proc., 18, 56–70.PubMedGoogle Scholar
  77. 77.
    Teraoka, S., Sanaka, T., Takahashi, K., Toma, H., Yamaguchi, Y., Yagisawa, T., Tanake, K., Sato, H., Matsumura, O. and Nakajima, 1. (1988) Stimulation of intrinsic prostacyclin synthesis and inhibition of thromboxane production to minimize cyclosporine nephrotoxicity. Transplant. Proc., 20, 638–645.PubMedGoogle Scholar
  78. 78.
    Skyler, J. S. (1988) Cyclosporine in insulin-dependent diabetes mellitus: effects on islet beta cell function. Transplant. Froc., (In press).Google Scholar
  79. 79.
    Traeger, J., Dubernard, J. M., Pozza, G. (1983) Influence of immunosuppressive therapy on the endocrine function of segmental pancreatic allografts. Transplant. Proc., 15, 1326–1329.Google Scholar
  80. 80.
    Stiller, C. R., Dupre, J. and Gent, M. (1984) Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science, 223, 1362–1367.PubMedGoogle Scholar
  81. 81.
    Assan, R., Feutren, G., Debray-Sachs, M., Quiniou-Debrie, M. C., Laborie, C., Thomas, G., Chatenoud, L. and Bach, J. F. (1985) Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet, 1, 67–71.PubMedGoogle Scholar
  82. 82.
    Gunnarson, R., Klintmaln, R., Lundgren, G., Wilczec, H., Östman, J. and Groth, C. G. (1983) Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet, 2, 571–572.Google Scholar
  83. 83.
    Harris, K. P. G., Russell, G. I., Parvin, S. D., Veitch, P. S. and Walls, J. (1986) Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br. Med. J., 292, 16.Google Scholar
  84. 84.
    Nakai, I., Omori, Y., Aikawa, I., Yasumura, T., Suzuki, S., Yashimura, N., Arakawa, K., Matsui, S. and Oka, T. (1988) Effect of cyclosporine on glucose metabolism in kidney transplant recipients. Transplant. Proc., 20, 969–978.PubMedGoogle Scholar
  85. 85.
    Whiting, P. TL, Thomson, K. J., Saunders, N. J. and Simpson, J. G. (1987) The effect of cyclosporin A on glucose tolerance and renal function in the normal rat. Diabetic Med. 4, 352.Google Scholar
  86. 86.
    Hahn, H. J., Laube, F., Lucke, S., Klötting, I., Kohnert, K. D. and Warzock, R. (1986) Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats. Transplantation, 41, 44–47.PubMedGoogle Scholar
  87. 87.
    Helmchen, U., Schmidt, W. E., Siegel, E. G. and Creutzfeldt, W. (1984) Morphological and functional changes of pancreatic ß-cells in cyclosporine-A-treated rats. Diabetologia, 27, 416–418.PubMedGoogle Scholar
  88. 88.
    Betschart, J., Virji, M. and Shinozuka, H. (1988) Cyclosporine-induced alterations in rat hepatic glycogen metabolism. Transplant. Proc. 20 (Suppl. 3), 880–884.PubMedGoogle Scholar
  89. 89.
    Yale, J. F., Roy, R. D., Grose, M., Seemayer, T. A., Murphy, G. F. and Marliss, E. B. (1985) Effects of cyclosporine on glucose tolerance in the rat. Diabetes, 34, 1309–131.PubMedGoogle Scholar
  90. 90.
    Garvin, P. J., Niehoff, M. and Staggenborg, J. (1988) Cyclosporine’s effect on canine pancreatic endocrine function. Transplantation, 45, 1027–1031.PubMedGoogle Scholar
  91. 91.
    Müller, M. K., Bergmann, K., Degenhardt, H., Klöppel, G., Löhr, M., Coone, H. J. and Goebell, H. (1988) Differential sensitivity of rat exocrine and endocrine pancreas to cyclosporine. Transplantation, 45, 698–700.PubMedGoogle Scholar
  92. 92.
    Yale, J-F., Chamellian, M., Courchesne, S. and Vigeant, C. (1988) Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment. Transplant. Proc., 20 (Suppl. 3), 955–958.Google Scholar
  93. 93.
    Buss, W., Stepanek, J. and Bennett, W. M. (1988) Proposed mechanism of cyclosporine toxicity: inhibition of protein synthesis. Transplant. Proc., 20 (Suppl. 3), 863–867.PubMedGoogle Scholar
  94. 94.
    Backman, L., AppelKwist, E-L., Ringden, O. and Dallner, G. (1988) Effects of cyclosporine on hepatic protein synthesis. Transplant. Proc., 20 (Suppl. 3), 853–858.PubMedGoogle Scholar
  95. 95.
    Suzuki, S., Oka, T., Ohkurna, S. and Kuriyama, K. (1987) Biochemical mechanisms underlying cyclosporine-induced nephrotoxicity. Transplantation, 44, 363–368.PubMedGoogle Scholar
  96. 96.
    Rossaro, L., Dowd, S., Ho, C. and Van Thiel, D. (1988) 19F nuclear magnetic resonance studies of cyclosporine and model unilamellar vesicles: where does the drug sit within the membrane? Transplant. Proc., 20 (Suppl. 3), 41–45.PubMedGoogle Scholar
  97. 97.
    Citterio, F. and Kahan, B. D. (1988) Effects of cyclosporine on the nuclear function. Transplant. Proc., 20, 75–79.PubMedGoogle Scholar
  98. 98.
    Chan, P., Scoble, J. E., Senior, J. C. M., Sweny, P., Varghese, Z. and Moorhead, J. F. (1989) Cyclosporin inhibition of glucose transport in a renal proximal tubular cell line. Transplant. Proc., 21, 922–923.PubMedGoogle Scholar
  99. 99.
    Kumano, K., Yoshida, K., Iwamura, M., Endo, T., Sakai, T., Nakamura, K. and Kuwao, T. (1989) Oxygen free radical scavengers reduce cyclosporine A nephrotoxicity in the rat. Transplant. Proc., 21, 941–942.PubMedGoogle Scholar
  100. 100.
    Hall, B. M., Tiller, D. J., Duggin, G. G., Horvath, J. S., Farnsworth, A., May, J., Johnson, J. R, and Sheil, A. G. R. (1985) Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine. Kidney Int., 28, 178–186.PubMedGoogle Scholar
  101. 101.
    Pichlmayer, R., Wonigeit, K., Ringe, B, Block, T., Raab, R., Heigel, B. and Neubaus, P. (1984) Rejection and nephrotoxicity, diagnostic problems with cyclosporine in renal Transplantation. Proc. EDTA-ERA, 21, 947–960.Google Scholar
  102. 102.
    Whiting, P. H., Duncan, J. I., Gavin, M. P., Heys, S. D., Simpson, J. G., Asfar, S. K. and Thomson, A. W. (1985) Renal function in rats treated with cyclosporin following unilateral nephrectomy. Br. J. Exp. Pathol., 66, 535–542.PubMedGoogle Scholar
  103. 103.
    Thiel, G., Brunner, F. P., Heimle, M., Stahl, R. A. K. and Mihatsch, M. J. (1986) Effect of cyclosporine A on ischaemic renal failure in the rat. Clin. Nephrol., 25 (Suppl. 1), S155–S161.PubMedGoogle Scholar
  104. 104.
    Iaina, A., Herzog, D., Cohen, D., Gavendo, S., Kapuler, S., Serban, I., Schiby, G. and Eliahou, H. E. (1986) Calcium entry-blockade with verapamil in cyclosporine A plus ischemia-induced acute renal failure in rats. Clin. Nephrol., 25 (Suppl. 1), S168–S170.PubMedGoogle Scholar
  105. 105.
    Hay, R., Tammi, K., Ryffel, B. and Mihatsch, M. J. (1986) Alterations in molecular structure of renal mitochondria associated with cyclosporine A treatment. Clin. Nephrol., 25 (Suppl. 1), S23–S26.PubMedGoogle Scholar
  106. 106.
    Khauli, R., Strzelecki, T., Stoff, J. and Menon, M. (1988) Cyclosporine-ischemia effects in the rat kidney: further biochemical observations with emphasis on calcium handling. Transplant. Proc., 20, 551–555.PubMedGoogle Scholar
  107. 107.
    Jung, K. and Pergande, M. (1985) Influence of cyclosporin A on the respiration of isolated rat kidney. FEES Lett., 183, 167.Google Scholar
  108. 108.
    Jung, K., Reinholdt, C., and Scholz, D. (1987). Inhibited efficiency of kidney mitochondria isolated from rats treated with cyclosporin A. Nephron, 45, 43–47.PubMedGoogle Scholar
  109. 109.
    Sangalli, L., Bortolotti, A., Passerini, F. and Bonati, M. (1989) Placental transfer, tissue distribution, and pharmacokinetics of cyclosporine in the pregnant rabbit. Transplantation (In press).Google Scholar
  110. 110.
    Deeg, H. J., Kennedy, M. S., Sanders, J. E., Thomas, E. D. and Storb, R. (1983) Successful pregnancy after marrow transplantation for severe aplastic anemia and immunosuppression with cyclosporine. J. Am. Med. Assoc., 250, 647.Google Scholar
  111. 111.
    Lewis, G. J., Lamont, C. A. R., Leel, H. A. and Slapak, M. (1983) Successful pregnancy in a renal transplant recipient taking cyclosporin A. Br. Med. J., 286, 603–604.Google Scholar
  112. 112.
    Klintmalm, G., Althoff, P., Appleby, G. and Segerbrandt, E. (1984) Renal function in a newborn baby delivered of a renal transplant patient taking cyclosporine. Transplantation, 38, 198–199.PubMedGoogle Scholar
  113. 113.
    Pickerell, M. D., Sawers, R. and Michael, J. (1988) Pregnancy after renal transplantation: severe intra-uterine growth retardation during treatment with cyclosporin A. Br. Med. J., 296, 825.Google Scholar
  114. 114.
    Zschauer, A. and Hodel, Ch. (1980) Drug-induced changes in rat seminiferous tubular epithelium. Arch. Toxicol., Suppl. 4, 466–470.Google Scholar
  115. 115.
    Matter, B. E., Donatsch, P., Rocine, R. R., Schmid, B. and Suter, W. (1982) Genotoxicity evaluation of cyclosporin A, a new immunosuppressive agent. Mutation Res., 105, 257–264.PubMedGoogle Scholar
  116. 116.
    Mason, R. J., Thomson, A. W., Whiting, P. H., Gray, E. S., Brown, P. A. J., Catto, G. R. D. and Simpson, J. G. (1985) Cyclosporine-induced fetotoxicity in the rat. Transplantation, 39, 9–12.PubMedGoogle Scholar
  117. 117.
    Brown, P. A. J., Gray, E. S., Whiting, P. H., Simpson, J. G. and Thomson, A. W. (1985) Effects of cyclosporin A on fetal development in the rat. Biol. Neonate, 48, 172–180.PubMedGoogle Scholar
  118. 118.
    Pennock, J. L., Reitz, B. A., Bieber, C. P., Jamieson, S. W., Burton, N. A., Raney, A. A., Oyer, P. E. and Stinson, E. B. (1980) Lethal complications due to cyclosporin A immune suppression with combination drug and combined heart and lung transplantation. Surg. Forum, 31, 375–378.Google Scholar
  119. 119.
    Reitz, B. A., Bieber, C. P. and Pennock, J. L. (1982) Cyclosporin A and lymphoma in non-human primates. In White, D. J. G. (ed.), (Amsterdam: Elsevier), pp. 317–328.Google Scholar
  120. 120.
    Borleffs, J. C. C., Neuhaus, P., Marquet, R. L., Zurcher, C. and Balmer, H. (1982) Cyclosporin A and kidney transplantation in rhesus monkeys. In White, D. J. G. (ed.), Cyclosporin A (Amsterdam: Elsevier), pp. 329–342.Google Scholar
  121. 121.
    Deeg, H. J., Hackman, R. C., Weiden, P. L. and Storb, R. (1982) Growth of canine tumours transplanted into normal adult dogs immtmosuppressed by cyclosporin A. Immunol. Immunother., 12, 147–152.Google Scholar
  122. 122.
    Kreis, W. and Soricelli, A. (1979) Cyclosporins: immunosuppressive agents with antitumour activity. Experimentia, 35, 1506–1508.Google Scholar
  123. 123.
    Thomson, A. W., Forrest, E. M., Smart, L. M., Sewell, H. F., Whiting, P. H. and Davidson, R. J. L. (1988) Influence of cyclosporin A on growth of an acute T-cell leukaemia in PVG rats. Int. J. Cancer., 41, 473–479.Google Scholar
  124. 124.
    Hattori, A, Perera, M. I. R., Witkowski, L. A., Kunl, R W., Gill, T. J. and Shinozuka, H. (1986) Accelerated development of spontaneous thymic lymphomas in male AKR mice receiving cyclosporine. Transplantation, 41, 784–786.PubMedGoogle Scholar
  125. 125.
    Shinozuka, H., Gill, T. J., Kurtz, H. W., Witkowski, L. A., Dimitris, A. J. and Perera, M. I. R. (1988) Enhancement of the induction of murine thymic lymphomas by cyclosporine. Transplantation, 41, 377–380.Google Scholar
  126. 126.
    Eccles, S. A., Hedeford, S. E. and Alexander, P. (1980) Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours. Br. J. Cancer., 42, 252–259.PubMedGoogle Scholar
  127. 127.
    Alexander, P. (1982) Cyclosporin A and the growth, dissemination and induction of tumours. In White, D. J. G. (ed.), (Amsterdam: Elsevier), pp. 299–305.Google Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Paul H. Whiting
  • Angus W. Thompson

There are no affiliations available

Personalised recommendations